Performance, Metabolism & Energy · Antioxidant

Alpha-Lipoic Acid (ALA)

★★★☆☆ Moderate Evidence Generally Safe
🟡Useful only in specific situations

Solid clinical evidence supports use for diabetic neuropathy symptom relief (its best-studied application), but evidence for general antioxidant, anti-aging, or weight-loss benefits in healthy people is much weaker and less consistent.

1. Overview

What it is

A naturally occurring compound synthesized in small amounts by the body and found in some foods, notable for being both water- and fat-soluble, allowing it to act as an antioxidant throughout the body.

How it works

Functions as a cofactor for key mitochondrial energy-producing enzymes and acts as a potent antioxidant, regenerating other antioxidants like vitamins C and E.

Who should take it

People with diabetic peripheral neuropathy (its best-studied clinical use, often used in Germany as a prescription treatment) under medical guidance.

Who should avoid it

People with thiamine (vitamin B1) deficiency should address that first, as ALA can worsen thiamine deficiency symptoms in rare cases; discuss with a physician if on diabetes medication.

Evidence summary

Multiple RCTs and meta-analyses, particularly from European research, support reduced neuropathic pain and improved nerve conduction measures in diabetic peripheral neuropathy with intravenous and, to a lesser extent, oral ALA; evidence for general health benefits in non-diabetic, healthy populations is much more limited.

Scientific mechanism

Acts as a cofactor for pyruvate dehydrogenase and other mitochondrial enzymes central to energy metabolism, and its antioxidant activity may reduce oxidative nerve damage implicated in diabetic neuropathy.

2. Scientific Evidence Rating

★★★☆☆

Moderate Evidence — based on high-quality human evidence including systematic reviews, meta-analyses, randomized controlled trials, and major clinical guidance where available.

Ratings reflect the overall quality and consistency of human evidence, not marketing claims. Where evidence is mixed, this is stated explicitly rather than rounded up.

3. Safety Rating

Generally Safe

4. Is It Worth Taking?

🟡Useful only in specific situations

Solid clinical evidence supports use for diabetic neuropathy symptom relief (its best-studied application), but evidence for general antioxidant, anti-aging, or weight-loss benefits in healthy people is much weaker and less consistent.

5. Benefits

Each benefit is tagged with its own evidence strength — not every claim about a supplement is equally well supported.

  • ★★★★☆ Reduces neuropathic pain symptoms in diabetic peripheral neuropathy
  • ★★★☆☆ May modestly improve insulin sensitivity in people with type 2 diabetes
  • ★★☆☆☆ Antioxidant activity is well demonstrated in laboratory studies, translation to broad human health outcomes in non-diabetics is less established
  • ★☆☆☆☆ General anti-aging and weight-loss marketing claims are not well supported by strong evidence

6. Risks

Side effects

GI upset (nausea, stomach discomfort) is the most common; rare skin rash.

Drug interactions

May enhance the blood-sugar-lowering effect of insulin and oral diabetes medications, increasing hypoglycemia risk; may modestly affect thyroid hormone levels with long-term use.

Who should avoid it / use caution

🤰 PregnancyInsufficient safety data for supplemental doses; not typically recommended.
🍼 BreastfeedingInsufficient safety data for supplemental doses.
🫘 Kidney DiseaseDiscuss with a physician for individualized guidance.
🫀 Liver DiseaseDiscuss with a physician — some research explores its use in liver conditions, but self-supplementation isn't advised.
🧒 ChildrenNot typically recommended outside specific medical protocols.
👴 Older AdultsGenerally well tolerated; caution if on diabetes medication.

7. Recommended Dosage

Adults (general)300–600 mg/day, the range most used in diabetic neuropathy trials, typically for at least 3-5 weeks before assessing effect
MenSame as general adult guidance
WomenSame as general adult guidance
Older Adults300–600 mg/day, a commonly studied population for neuropathy indications
AthletesNo strong specific performance-related evidence established
VegetariansFully suitable (synthesized, not animal-derived)
VegansFully suitable
Upper Safe Limit (UL)No formal UL established; doses up to 1,800mg/day used short-term in some clinical trials without major safety signals

8. Best Time To Take

  • On an empty stomach, 30 minutes before a meal, for optimal absorption in most studied protocols
  • Consistent daily use over several weeks needed to see neuropathy-related benefits

9. Food Sources

  • Organ meats (kidney, liver, heart)
  • Broccoli
  • Spinach
  • Tomatoes
  • Brussels sprouts — dietary amounts are far lower than therapeutic supplemental doses

10. Deficiency Symptoms

Supplementation is most clearly evidence-based when it corrects an actual shortfall like the ones below — not as a routine addition for people who are already sufficient.

  • Not an essential nutrient with a classical deficiency syndrome, since the body synthesizes its own ALA

FAQ

Can ALA replace diabetic neuropathy medication?

No — it should be used as directed by a physician alongside, not instead of, standard diabetes and neuropathy management.

Is ALA the same as omega-3 ALA (alpha-linolenic acid)?

No — despite the similar abbreviation, alpha-lipoic acid and alpha-linolenic acid (a plant omega-3 fat) are completely different compounds.

11. Scientific References

Ratings and content on this page are based on the consensus of the following types of high-quality sources. This is educational information, not individual medical advice.

Key Research Papers

General Reference Organizations

⚕️ This page does not diagnose, treat, cure, or prevent any disease. Alpha-Lipoic Acid (ALA) is not a substitute for a varied diet or professional medical care. Always consult a qualified healthcare provider before starting any new supplement, especially if pregnant, breastfeeding, managing a health condition, or taking medication.

← Back to full Supplement Guide